Skip to main content

Topic

Patent Information

3 published works

  1. Big Molecule Watch

    Purple Book Updates

    By Alexandra Valenti

    In 2021, the FDA’s Purple Book went live, providing a searchable database of licensed biological products, including the patent information provided to biosimilar applicants during the patent dance.  Pursuant to a law enacted…

  2. Life Science Legal Report

    Orange Book Transparency Act of 2020 Signed Into Law

    By Bryan D. Beel, Perkins Coie

    On January 5, 2021, the Orange Book Transparency Act of 2020, H.R. 1503, was signed into law. H.R. 1503 amends provisions of the Federal Food, Drug, and Cosmetic Act (“FDCA”)…

  3. ILN IP Insider

    Information on Filed Applications for Registration of Drugs has Become Publicly Available in Russia

    By Boris Malakhov of Lidings Law Firm

    Under the Federal Law “On drugs circulation” (Law), information on state registration of drugs in Russia shall be publicly available. Pursuant to Art. 37(1) of the Law, MoH-s obligation is to…